Skip to content
OpenCapital
Get started

Mirum Pharmaceuticals, Inc. MIRM Market capitalization

Market capitalization at other companies

Gilead Sciences logo
Gilead SciencesGILD
$172.99B+23.8%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$5.94B+77.3%
Arrowhead Research logo
Arrowhead ResearchARWR
$8.78B+402%
LQD
Liquidia CorporationLQDA
$3.33B+164%
Alkermes logo
AlkermesALKS
$5.89B+9.7%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$12.4B+159%

Other financials

Income statement

See full
Revenue$159.9M+43.3%
Operating income-$789.5M-5,100%
Net income-$790.2M-5,284%
EPS (diluted)-$13.43-4,377%

Balance sheet

See full
Cash & equivalents$261.5M+43.5%
Total debt$13.5M+56.4%
Total equity$242.5M+4.0%
Total assets$890.9M+29.1%

Cash flow

See full
Operating cash flow-$228.8M-11,566%
CapEx$664.0K+1,520%
Free cash flow-$229.4M-11,360%

Valuation

See full
Enterprise value$6.28B+162%
P/S11.5×+4.6×

Profitability

See full
Operating margin-139.8%-168pp
Net margin-140.2%-169pp
FCF margin-30.3%—

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.1×-1.1×

Where this comes from

Computed from the period-end share price: $5.57B.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s market capitalization?
Mirum Pharmaceuticals, Inc. (MIRM) reported market capitalization of $5.57B in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
Mirum Pharmaceuticals, Inc.'s market capitalization increased by 152.5% year-over-year, from $2.21B to $5.57B.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s market capitalization has grown at a 50.1% compound annual growth rate (CAGR), from $534.94M to $4.08B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.